MONOMORPHIC EPITHELIOTROPIC INTESTINAL T-CELL LYMPHOMA
Clinical trials for MONOMORPHIC EPITHELIOTROPIC INTESTINAL T-CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new MONOMORPHIC EPITHELIOTROPIC INTESTINAL T-CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for MONOMORPHIC EPITHELIOTROPIC INTESTINAL T-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo tested for aggressive blood cancer
Disease control TerminatedThis study aimed to see if adding the drug tazemetostat to standard CHOP chemotherapy could be more effective for people newly diagnosed with certain types of T cell lymphoma. The trial planned to enroll about 24 adults and measure how well the combination worked to eliminate the…
Matched conditions: MONOMORPHIC EPITHELIOTROPIC INTESTINAL T-CELL LYMPHOMA
Phase: PHASE2 • Sponsor: Eric Jacobsen, MD • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
New hope for Tough-to-Treat blood cancer? trial tests adding drugs to standard chemo
Disease control TerminatedThis study aims to see if adding one of two new drugs (duvelisib or CC-486) to a standard chemotherapy regimen works better for treating newly diagnosed peripheral T-cell lymphoma, a rare and aggressive blood cancer. It will compare the complete remission rates and side effects b…
Matched conditions: MONOMORPHIC EPITHELIOTROPIC INTESTINAL T-CELL LYMPHOMA
Phase: PHASE2 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Mar 31, 2026 12:22 UTC